Photocure ASA announced its participation in the American Urological Association Annual Congress (AUA 2024) to be held May 3-6, 2024 in San Antonio, TX, USA. Two AUA program highlights will feature Blue Light Cystoscopy with Cysview study data: On May 5th, Dr. Sanjay Das will present the study, "Use of Blue Light Cystoscopy Among Non-Muscle Invasive Bladder Cancer Patients and Outcomes in an Equal Access setting: A Propensity Scored Matched Analysis" The study, known as BRAVO (Bladder Cancer Recurrence Analysis in Veterans and Outcomes), is a retrospective, Propensity score matched analysis that evaluated oncologic outcomes following BLC compared to WLC alone in patients from the Veterans Affairs (VA) Healthcare System. This pooled meta-analysis includes data from a randomized clinical trial and a supporting real-world evidence study conducted in China.